A family tragedy sent two founders after one of medicine's most subjective rituals. Their bet: short phone tests can make the months between neurology visits visible - if patients, doctors and drug developers trust the measurements.
Respiree is a Singapore-founded digital health company (an A*STAR spin-off) building clinically validated AI that pairs FDA-cleared cardio-respiratory wearable sensors with software to track lung and heart biomarkers over time. Its 1Bio platform helps hospitals, health systems and biopharma detect patient deterioration - such as COPD flare-ups and heart failure - days in advance, powering remote patient monitoring, clinical decision support and decentralized clinical trials across Asia-Pacific, Australia and the United States.
Huma is a London-based digital health technology company that builds a regulated, modular software platform used by hospitals, pharmaceutical companies and governments to run remote patient monitoring, 'hospital at home', companion apps and decentralized clinical trials. Founded in 2011 as Medopad and rebranded to Huma in 2020, it combines predictive algorithms, digital biomarkers and real-world data with a no-code Huma Cloud Platform so partners can launch regulated, disease- and device-agnostic health apps. Its Software as a Medical Device holds EU MDR Class IIb, US FDA Class II and UK MHRA registrations, and its technology has reached thousands of hospitals and tens of millions of patients worldwide.
Azumio is a Redwood City, California digital health company that builds AI-powered mobile apps and developer APIs for tracking heart rate, food, sleep, fitness and diabetes. Founded in 2011 out of the runaway success of its Instant Heart Rate app, Azumio's consumer titles - including Argus, Calorie Mama, Glucose Buddy, Fitness Buddy and Sleep Time - have collectively surpassed 100 million downloads. The company also licenses its computer-vision technology to businesses through the Calorie Mama / Food Lens food-recognition API and its Instant Diabetes Test and health-data platform APIs.
Cardiosense is a Chicago-based health-tech company building an AI platform that turns raw physiological signals into clinical intelligence for heart failure. Its FDA-cleared CardioTag wearable simultaneously captures ECG, PPG and seismocardiogram (SCG) signals, and its machine-learning algorithms estimate pulmonary capillary wedge pressure (PCWP) - a key measure of cardiac filling pressure - noninvasively, so clinicians can spot a worsening heart before it lands a patient in the hospital.
Progentec Diagnostics is an Oklahoma City company building blood-based biomarker tests and digital health tools for autoimmune diseases, starting with lupus. Its lead product, the aiSLE DX Flare Risk Index, uses an 11-biomarker algorithm to predict a lupus flare up to 12 weeks before it happens, giving rheumatologists a chance to intervene early. Spun out of research tied to the Oklahoma Medical Research Foundation, the company pairs lab science with patient-facing tools like the LupusCorner community to move autoimmune care from reactive to proactive.
Evidation is a digital health company that gathers real-world health data from millions of consenting individuals through its Achievement app, turning everyday signals from wearables, sleep, activity and surveys into insights for clinical research, life sciences partners, and personalized health programs.